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Megan FlynnA U T H O R
One milimolar is one
micromole per
milliliter, which is . . .
Background
“One milimolar is one micromole per milliliter,
which is one nmole per microliter… if you take
the K
m
 of AdoMet for LSMT and you are in a pre-
steady state system…”
When I began research in Dr. Robert Houtz’s
lab in January, 2002, I heard a lot of this… very
quick, concise information… but to me, mumbling
that didn’t quite make sense where some words
rang a bell.  I felt that my year and half of college
training was quite insufficient for successful dis-
cernment of Dr. Houtz’s instructions and sugges-
tions.  However, after acquiring explicit written
directions of what he was trying to communicate
and a little trial and error, I began to understand
and flourish with scientific research.
Up to that point academically, I was one of
numerous undecided college students.  I had
started in the Biosystems Engineering program at
UK, but found this to be unaligned with my inter-
ests.  Also, I knew I wasn’t “pre-med/vet/dental/
pharmacy/P.A./P.T., etc.,” which almost everyone
else who studies biological sciences seems to be.
However, after being fully immersed in my research
and experiencing the joy of a successful, data-pro-
ducing experiment, I decided that a Ph.D. followed
by a teaching/research position at a large univer-
sity might be the right path.
My first significant contribution to my lab’s
work was in the summer of 2002.  Up to that time
I was learning basic skills and deciding what type
of project I wanted to devote myself to.  The en-
zyme that I work with, Rubisco Large Subunit
Methyltransferase (LSMT), had been classified as
containing a newly identified protein fold, the SET
domain.  This fold is ubiquitous to almost all or-
ganisms and is of great interest, because it is found
in some proteins that influence gene silencing,
chromatin formation, and certain cancers.  Con-
sequently, National Institutes of Health crystallog-
rapher, Dr. Jim Hurley, became interested in our
enzyme and solved its 3-D structure.  I was then
able to learn first hand the difficulty and the beauty of enzyme kinetics.
The lab’s efforts turned into a publication in the prestigious journal Cell,
with two other crystal structures of SET domain containing proteins in
the issue.  A précis of the three articles clearly stated that our paper was
the best (and made the cover!) due to the resolution of the structure and
the extensive functional data.
There are two types of people as far as enzyme kinetics are con-
cerned: those who understand them and those who don’t.  The learning
curve is steep, mainly because after fully understanding kinetic con-
stants, which are usually denoted by k and some subscript (k
cat
, k
m
, k
a
,
k
d
, K
D
, k
ia
, k
i
, etc.), you comprehend the majority of enzyme kinetics.
Second, you have to learn how to interpret the complex data and be able
to know when the values you obtain are reasonable or are not, a skill
that develops with time.  I am proud to say that I have become proficient
in enzyme kinetics, which has not only trained me to be very precise,
but has also helped make me become a better experimentalist.
Undergraduate research is extremely rewarding.  Not only do I know
a little bit about enzyme kinetics, I have been published, and have be-
come well versed in other areas of experimental biology.  I appreciate
the evolution I have made as a student due to undergraduate research —
now I am more analytical, critical, and capable of designing and imple-
menting independent thought.  I feel that I have gotten the most out of
my education and have truly prepared myself for the next step — gradu-
ate school at the University of California at Berkeley.
Now, new students in the lab look at me in a similar, puzzled way as
I did to Dr. Houtz two years ago.  I take great pride in being a legitimate
source of information and a person who can analyze data and teach
certain skills.  Furthermore, I feel lucky and humble to be on a career
path that I feel confident about and drawn to; as well, I am grateful for
all of the help I have received along the way.
Being awarded the Beckman scholarship has been a critical part of
my growth intellectually and scientifically while an undergraduate.  Re-
ceiving such a prestigious award serves as an affirmation of my abilities
and a source of encouragement to achieve more, and is a great reward
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for all of my efforts.  Furthermore, at the Beckman
Symposium in the summer, 2003, I interacted with
incredibly talented scientists.  This provided another
source of inspiration to become more proficient my-
self.
Although research may seem esoteric and nar-
row to some, all contributions of information are used
to solve larger problems.  I am pleased to take this
realization away and to have developed into a good
scientist during my undergraduate career.
My Research
Protein methylase III enzymes are a unique class of
post-translational processing enzymes responsible for
the mono-, di-, or tri-methylation of the e-amino
groups of internal lysyl residues in a diverse group of
proteins. Many S-adenosyl-L-methionine depen-
dent protein methyltransferases contain a highly
evolutionary conserved secondary structural do-
main composed of 110 amino acids known as the
SET (Suppressor of variagation 3-9, Enhancer of
zeste, Trithorax) domain.  During my time as a
Beckman scholar, I have investigated and largely
characterized specific functions of Rubisco LSMT,
a member of this group, using structure as a guide.
Rubisco LSMT: investigation of successive
methyl transfers
First, I have focused on the trimethylation by Rubisco
LSMT on Lysine 14 of large subunits.  Kinetic analy-
sis of LSMT reveals characteristics of a ping-pong
reaction mechanism; however, similar analysis of
SET7/9, a histone methyltransferase that catalyzes
the mono-methylation of histone H3 Lys-4, is ran-
dom order.  Because the disassociation constant (K
D
)
for the Rubisco LSMT complex is approximately
50,000 times lower than the Michaelis constant (K
M
)
of the enzyme for Rubisco, the kinetic plots may be
distorted from the actual reaction mechanism.
Alternatively, the bi-polar arrangement of
substrate binding sites in the SET domain are
geometrically ideal for successive methyltransfers
without disassociation of the protein substrate, and
this phenomenon could be responsible for the
appearance of a ping-pong like reaction mechanism.
A SET7/9 mutant, Y305F, performs both mono- and
di-methylation of histone H3, and its kinetics are
altered in a manner that resembles the distorted plots
of the reaction mechanism of LSMT.  The similarity
in the kinetic plots of LSMT and the SET7/9 Y305F
mutant suggests that each enzyme obeys the same
reaction mechanism and that the protein substrate
remains bound during consecutive methyltransfers.
Through product analysis, I have found that
Rubisco LSMT is a processive enzyme.  That is, three
methyl transfers occur before the enzyme dissociates
from the protein substrate Rubsico.  This finding cor-
roborates structural data that would suggest a succes-
sive mechanism of methylation.
Rubisco LSMT: a structurally unique enzyme
Rubisco LSMT is the only SET domain containing pro-
tein with a structurally unique C-terminal domain,
while the N-terminal domain of the enzyme contains
the functional SET motif.  Thus, to examine the role
that the C-terminal domain plays in catalysis as well
as substrate binding, I have expressed truncated clones
of the LSMT enzyme.  These attempts may help de-
termine if the C-terminal lobe of LSMT has a struc-
tural or biochemical importance.
Based on models mimicking the binding
between Rubisco LSMT and Rubisco, the C-terminal
domain may contribute to the specificity and
interaction between these two proteins.  Also,
expression of N-terminally truncated forms of
Rubisco and subsequent binding analysis using
ELISA suggest that the C-terminal domain can
interact with Rubisco in the absence of the N-
terminal catalytic SET domain.  I am investigating
homologous Open Reading Frames (ORFs) from
humans and mice for analysis of protein
methyltransferase activity and the role, if any, that
the C-terminal domain assumes in these proteins.
The function of the C-termini in the interaction of
Rubisco and Rubisco LSMT may have important
implications for other protein methyltransferases
given that this sequence is found with 80%
consensus in Neurospora crassa, Drosophila
melongaster, Bos Taurus, and Sus scrofa.
Conclusion
My work in the Houtz lab has helped reveal more
functional/mechanistic data about Rubisco LSMT, a
SET domain-containing protein methyltransferase.  I
have found that it is a processive enzyme, which helps
explain its distorted reaction mechanism kinetics.
Furthermore, I have explored the structurally unique
C-terminal domain of the enzyme and found that it is
essential for binding to the protein substrate Rubsico
and truncated forms of the enzyme possess no enzy-
matic activity.  This information is of great signifi-
cance because it reveals more information about a
class of proteins with SET domains.  SET domain-
containing proteins are found in many organisms, in-
cluding human histone methyltransferases that are
linked to human cancers, chromatin compaction, and
gene silencing.
